aaiPharma Situation Underscores The Need for Due Diligence

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2004, Volume 28, Issue 5

Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookPharmaceutical Technology-05-02-2004
Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform
BARDA Awards Gritstone bio $433 Million Contract for Phase IIb Study of Next-Gen COVID-19 Vaccine
MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production